Trials / Unknown
UnknownNCT03692234
Homoarginine Supplementation in Patients After Stroke
Homoarginine in Stroke (HiS) Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study represents a follow-up of the previous study "Single and Multiple Doses of an Oral Formulation of L-Homoarginine in Healthy Human Subjects" (NCT02675660). This study will evaluate the applicability of an oral formulation of L-homoarginine to normalize homoarginine blood levels in patients with acute ischemic stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 125 mg L-homoarginine | capsules for oral supplementation |
| OTHER | placebo | capsules for oral supplementation |
Timeline
- Start date
- 2018-08-22
- Primary completion
- 2022-12-01
- Completion
- 2023-08-01
- First posted
- 2018-10-02
- Last updated
- 2021-07-02
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03692234. Inclusion in this directory is not an endorsement.